Since its launch four years ago, the self-service DNA Encoded Library (DEL) has been adopted by thousands of academic and industry research teams. But just as drug development has evolved with innovation, so has the DEL.

These advancements provide solutions to covalent hit discovery, hit validation, and machine learning. Please join WuXi AppTec, the pioneer in DEL technology, for this webinar to find out more about how this next-gen technology can accelerate your drug discovery.

WHO SHOULD ATTEND

• Academics interested in screening their (protein/biomolecule) targets for drug-like chemical matter using freely accessible DELs.
• Industry scientists interested in conducting DEL screens without revealing target identity and/or developing proprietary screening techniques in their own labs.
• Scientists interested in protein-ligand interactions and the associated omics and machine learning research.

WHAT WILL BE LEARNED

• Basics of how the DEL kit works
• Introduction of next generation of DEL capabilities
• Applications of these capabilities